Atrium Therapeutics
RNA
Atrium Therapeutics (RNA) news
Recent news
Atrium Therapeutics, Inc.: H.C. Wainwright initiates coverage with buy rating and target price $25
AInvest Wire · Aug 6, 2026Atrium Therapeutics - first participant expected by end of 2026; initial data anticipated second half 2027
AInvest Wire · Jul 14, 2026Atrium Therapeutics announces inducement grants under Nasdaq listing rule 5635(c)(4)
AInvest Wire · Jun 23, 2026ImportantIRNA reported three offshore platforms at Iran's South Pars gas field have resumed production
AInvest Wire · May 31, 2026ImportantIran says exchange of messages with US is continuing: IRNA
AInvest Wire · May 29, 2026Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.